Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients
Published: April 04, 2019
- Left ventricular assist devices (LVAD) are used frequently for the management of patients with advanced heart failure and low ejection fraction.
- Atrial and ventricular arrhythmias are common in this setting, but there is no consensus on best practices for the management of these arrhythmias.
- This statement addresses the evidence and provides guidance on the management of atrial and ventricular arrhythmias in this unique patient population.
Supporting Materials
- Commentary: Insights from the AHA Scientific Statement on Managing Arrhythmias in Patients with Left Ventricular Assist Devices: Unique Challenges and Unanswered Questions by Jim Cheung, MD, FACC, FHRS
- Top Things to Know: Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients
Recommended Reading
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
- Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure
- Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care